James McKiernan, Mitchell C. Benson
Abstract |
Full text
|
PDF
R
isk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients .
